MaterMend Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
2
MaterMend General Information
Description
Provider of immediate treatments intended for accidents in epidural anesthesia. The company offers a patch that stops cerebrospinal fluid loss a few instants after an accidental dural puncture, enabling patients with some pain relief and ensuring a safe epidural anesthesia procedure.
Contact Information
Website
www.matermend.comCorporate Office
- Calle De La Marina, S/n.
- 46011 Valencia
- Spain
Corporate Office
- Calle De La Marina, S/n.
- 46011 Valencia
- Spain
MaterMend Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 15-Sep-2023 | Completed | Generating Revenue |
MaterMend Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MaterMend Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NLC Health Ventures | Venture Capital | Minority | ||
| Twilight Venture Partners | Venture Capital | Minority |
MaterMend FAQs
-
When was MaterMend founded?
MaterMend was founded in 2023.
-
Where is MaterMend headquartered?
MaterMend is headquartered in Valencia, Spain.
-
What industry is MaterMend in?
MaterMend’s primary industry is Other Healthcare Services.
-
Is MaterMend a private or public company?
MaterMend is a Private company.
-
What is MaterMend’s current revenue?
The current revenue for MaterMend is .
-
Who are MaterMend’s investors?
NLC Health Ventures and Twilight Venture Partners have invested in MaterMend.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
